Ryman Healthcare

Ryman Healthcare is a New Zealand retirement village, aged-care and healthcare-services company founded in Christchurch in 1984 by John Ryder and Kevin Hickman. Its name combines elements of the founders’ surnames. The company developed a business model that integrates retirement living, residential aged care and property development rather than treating accommodation and care as separate operations. Ryman’s villages generally provide a range of living and care options within one campus. These can include independent retirement apartments and villas, assisted living, rest-home care, hospital-level care and secure dementia care. The model is commonly described by the company as a continuum of care: residents may be able to remain within the same village as their accommodation and care needs change. Many villages are designed with amenities and clinical facilities intended to support a substantial resident community, including healthcare and dementia-care areas. A central element of the company’s commercial model is deferred management fees. Residents obtain a right to occupy an apartment, villa or unit under the applicable village contract, and the amount returned when the resident leaves or the occupancy right is transferred is reduced according to the contract’s terms. The Wikipedia reference describes a deduction capped at 20% after a period exceeding five years, although exact terms can vary by product, jurisdiction and contract. This model links recurring village development, resale and care operations. Ryman expanded beyond New Zealand into Australia in 2012, beginning with a development site at Wheelers Hill in eastern Melbourne, Victoria. It subsequently acquired or pursued additional development sites in Victoria, including locations at Brandon Park, Burwood East, Coburg, Mount Eliza, Mount Martha, Aberfeldie, Ocean Grove and Geelong. The company’s Australian strategy follows the same broad integrated-village concept while operating within Australian planning, retirement-living and aged-care regulations. The reference material describes Ryman as operating 48 villages in New Zealand and eight in Melbourne, with further developments under way in New Zealand and Victoria as of the cited material. It also reports more than 6,700 employees and more than 13,200 residents, although those figures are time-sensitive and are not assigned a separate reporting date in the supplied material. Ryman has historically been one of the larger companies on the New Zealand Exchange and has been included in the NZX 50 Index. Beyond its operating business, Ryman has used philanthropic and research initiatives to associate the brand with ageing, dementia, disability and quality-of-life innovation. In 2015 it supported the creation of the Ryman Prize, an annual award administered by the Ryman Foundation for an idea or advance that improves the lives of older people. The prize has recognized work in blindness prevention, dementia research, neurodegenerative disease, assistive robotics, spinal disorders, cognitive ageing and frailty. Ryman’s positioning is therefore based on an integrated, premium-oriented retirement-living proposition: housing, hospitality, community amenities and graduated care delivered through purpose-built villages. Its principal strategic challenges include the capital intensity of development, construction and completion risk, regulation of aged-care and retirement-village contracts, staffing requirements, resident safety and the need to maintain occupancy and service quality across two national markets.

Ryman Healthcare was established in Christchurch in 1984 by John Ryder and Kevin Hickman. The company’s name is derived from the two founders’ surnames. From its beginning, Ryman developed a model that combined retirement accommodation with aged-care services and property development. This approach enabled the company to offer residents several levels of support within a single village rather than requiring a move to an unrelated provider when care needs increased. The company’s villages typically combine independent retirement living with assisted living, rest-home services, hospital-level care and secure dementia units. This integrated structure became a defining feature of the Ryman proposition and is referred to by the company as a continuum of care. Villages are generally planned as sizeable communities with residential accommodation, shared amenities and healthcare facilities. Ryman also names its villages after New Zealand or Australian trailblazers, connecting the physical developments with a distinctive brand convention. Ryman’s financial and operating model combines development activity with ongoing healthcare and village services. Under the deferred-management-fee structure described in the supplied reference material, a resident receives a contractual right to occupy a unit or apartment. When the resident leaves, the resident or estate receives an amount determined by the contract, with a deduction that the reference describes as capped at 20% after more than five years. The precise economics depend on the legal agreement, service type and jurisdiction. This model gives Ryman exposure to property construction, village sales, occupancy, resale and care operations. The company expanded internationally in 2012 by acquiring a development site at Wheelers Hill in Melbourne, Victoria. It later added or pursued sites at Brandon Park, Burwood East, Coburg, Mount Eliza, Mount Martha, Aberfeldie, Ocean Grove and Geelong. Australia became Ryman’s principal market outside New Zealand, with the company concentrating its Australian development activity in Victoria. The Australian expansion required adaptation to local planning systems, retirement-village legislation, aged-care regulation and construction conditions. By the period covered by the supplied Wikipedia material, Ryman had 48 operational villages across New Zealand and eight in Melbourne, while continuing to develop additional sites in New Zealand and Victoria. The same material described a workforce of more than 6,700 people and a resident population exceeding 13,200. These figures illustrate the scale of the business but should be read as period-specific operating statistics rather than permanent totals. Ryman has also been a significant New Zealand listed company and was included in the NZX 50 Index. Ryman’s public profile has included business and healthcare awards. The supplied reference records recognition in value-creation rankings, a Deloitte Top 200 award for CEO Simon Challies in 2014 and a Deloitte Top 200 award for chairman David Kerr in 2013. It also records repeated Reader’s Digest New Zealand trusted-brand recognition and a Workbase growth-strategy award. These accolades formed part of the company’s reputation-building around growth, trust and aged-care expertise. In 2015, Ryman supported the creation of the Ryman Prize, administered by the Ryman Foundation. The annual NZD 250,000 award was designed to recognize an idea, innovation or advance that improves quality of life for older people. Winners listed in the reference materials include Gabi Hollows in 2015, Henry Brodaty in 2016, Peter St George-Hyslop in 2017, Takanori Shibata in 2018, Michael Fehlings in 2019, Miia Kivipelto in 2020, Kenneth Rockwood in 2021 and Perminder Sachdev in 2022. Their work spans preventable blindness, dementia, neurodegenerative disease, robotics, spinal health, cognitive ageing and frailty. Ryman’s development-led strategy offers scale and a broad service proposition, but it also creates exposure to construction costs, interest rates, development timing, occupancy, staffing, clinical quality and regulatory requirements. The company’s long-term identity remains tied to the integrated village: a branded environment intended to support independent living and progressively higher levels of aged care in both New Zealand and Australia.

• 2024

  Reported operating footprint

  [1]Ryman Healthcareen.wikipedia.org

  Reference material reports 48 operational New Zealand villages and eight Melbourne villages, alongside further development in New Zealand and Victoria.

• 2015

  Ryman Prize is launched

  [1]Ryman Healthcareen.wikipedia.org

  Ryman supports an annual award administered by the Ryman Foundation for advances improving older people’s quality of life.

• 2012

  Entry into Australia

  [1]Ryman Healthcareen.wikipedia.org

  Ryman acquires a development site at Wheelers Hill in eastern Melbourne, beginning its Australian expansion.

• 1984

  Ryman Healthcare is founded

  [1]Ryman Healthcareen.wikipedia.org

  John Ryder and Kevin Hickman establish the company in Christchurch, New Zealand.

Premium, integrated retirement living and aged care combining accommodation, community amenities and a continuum of clinical care.

• Retirement living · 1984

  Retirement villages

  Ryman’s core offering is a master-planned retirement village combining private accommodation with communal amenities and support services. Villages may include apartments, villas and shared spaces for recreation, dining, social activities and wellbeing. The villages are designed to provide an age-focused community while allowing residents to access additional services as their circumstances change. The occupancy and financial arrangements are generally structured through retirement-village contracts, including deferred-management-fee arrangements described in the company’s reference material.

• Independent retirement living · 1984

  Independent-living apartments and villas

  Independent-living accommodation is intended for residents who want a retirement community without requiring full-time residential care. Units are generally supported by village amenities, maintenance services and access to the wider Ryman care network. The offering forms the entry point of the company’s continuum-of-care concept, allowing residents to live independently while having services and care options available on the same campus or through the village’s operating structure.

• Aged care · 1984

  Assisted living

  Assisted living provides accommodation and day-to-day support for residents who need help with some activities but do not necessarily require hospital-level or full residential care. Within Ryman’s village model, assisted living is positioned between independent retirement living and more intensive clinical services. The service can help residents remain connected to the same community while receiving greater support with personal care, meals, medication or daily routines, subject to local service arrangements and eligibility.

• Rest-home and hospital care · 1984

  Residential aged care

  Ryman operates rest-home and higher-acuity residential aged-care services within its village network. These services are intended for people who can no longer live independently and require regular personal, nursing or clinical support. The integrated-village model is designed to reduce disruption by making different care levels available within a familiar community. Delivery is governed by national aged-care rules, clinical requirements and the specific operating arrangements of each facility.

• Specialist aged care · 1984

  Dementia care

  Many Ryman villages include secure dementia-care areas for residents living with dementia or related cognitive conditions. These environments are intended to provide supervision, structured routines, personal care and a safer setting than ordinary independent accommodation. Dementia care is a central component of the company’s continuum-of-care proposition and connects with Ryman’s public support for research into dementia, Alzheimer’s disease and cognitive ageing.

• 2015Ryman Prize

  New Zealand · Australia · International

  Ryman supported the creation of an annual NZD 250,000 prize administered by the Ryman Foundation. The programme recognizes research, technology or other advances intended to improve quality of life for older people.

  Outcome. The prize became a recurring international-facing philanthropic programme and recognized work across blindness prevention, dementia, neurodegenerative disease, robotics, spinal health, cognitive ageing and frailty.

  Source

• 2015

  Support the Ryman PrizeOther

  Background

  Ryman sought to support work addressing ageing and older people’s quality of life beyond its direct village and care operations.

  Action taken

  The company supported an annual prize administered by the Ryman Foundation, with an award value of NZD 250,000.

  Aftermath

  The initiative created a continuing philanthropic platform that recognized international researchers and innovators in ageing-related fields.

  Annual prize value. NZD 250,000 (From 2015; annual award value stated in the supplied reference material)

  Source

• 2012

  Enter the Australian retirement-village marketStrategy

  Background

  Ryman had established its operating base in New Zealand and identified Australia, particularly Victoria, as a market for its integrated retirement-living and aged-care model.

  Action taken

  The company acquired a development site at Wheelers Hill in eastern Melbourne and later pursued additional Victorian sites.

  Aftermath

  Australia became Ryman’s principal international market, with villages and development activity in Melbourne and other Victorian locations.

  Source

• 2024

  Ryman Healthcare reports a large operating village network[1]Ryman Healthcareen.wikipedia.org

  Other

  Reference material stated that, as of June 2024, Ryman operated 48 villages in New Zealand and eight in Melbourne, with additional villages being developed in New Zealand and Victoria.

• 2022

  Perminder Sachdev receives the Ryman Prize[1]Ryman Healthcareen.wikipedia.org

  Campaign · Other

  The award recognized Professor Perminder Sachdev’s long-term research into psychiatric disorders, dementia and ageing.

• 2021

  Kenneth Rockwood receives the Ryman Prize[1]Ryman Healthcareen.wikipedia.org

  Campaign · Other

  The prize recognized work on geriatric frailty measurement, including the development of a frailty index with Arnold Mitnitski.

• 2020

  Miia Kivipelto receives the Ryman Prize[1]Ryman Healthcareen.wikipedia.org

  Campaign · Other

  The award recognized research into cognitive impairment, Alzheimer’s disease and dementia prevention and treatment.

• 2019

  Michael Fehlings receives the Ryman Prize[1]Ryman Healthcareen.wikipedia.org

  Campaign · Other

  The prize recognized Dr Michael Fehlings’ research into degenerative cervical myelopathy, a spinal disorder affecting older people.

• 2018

  Takanori Shibata receives the Ryman Prize[1]Ryman Healthcareen.wikipedia.org

  Campaign · Other

  The award recognized Professor Takanori Shibata’s work on robotics and technology intended to assist older people.

• 2017

  Peter St George-Hyslop receives the Ryman Prize[1]Ryman Healthcareen.wikipedia.org

  Campaign · Other

  The award recognized research into neurodegenerative disease and genes associated with nerve-cell degeneration and early-onset Alzheimer’s disease.

• 2016

  Henry Brodaty receives the Ryman Prize[1]Ryman Healthcareen.wikipedia.org

  Campaign · Other

  The prize recognized Professor Henry Brodaty’s contributions to dementia, ageing and mental-health research.

• 2015

  Ryman Healthcare supports launch of the Ryman Prize[1]Ryman Healthcareen.wikipedia.org

  Campaign · Other

  The company announced support for an annual NZD 250,000 prize administered by the Ryman Foundation for innovations that improve quality of life for older people.

• 2015

  Gabi Hollows receives the inaugural Ryman Prize[1]Ryman Healthcareen.wikipedia.org

  Campaign · Other

  The first Ryman Prize recognized Gabi Hollows for work helping restore sight for people affected by preventable blindness.

Showing the 10 most recent.

1. 1Ryman Healthcareen.wikipedia.org
2. 2Ryman Healthcare official websiterymanhealthcare.co.nz
3. 3Ryman Healthcare Limited (NZX: RYM) Appoints New Group CEOsharechat.co.nz